JP2006513205A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513205A5 JP2006513205A5 JP2004563508A JP2004563508A JP2006513205A5 JP 2006513205 A5 JP2006513205 A5 JP 2006513205A5 JP 2004563508 A JP2004563508 A JP 2004563508A JP 2004563508 A JP2004563508 A JP 2004563508A JP 2006513205 A5 JP2006513205 A5 JP 2006513205A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydroxy
- methyl
- cycloalkyl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 35
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 21
- 125000000623 heterocyclic group Chemical group 0.000 claims 17
- -1 CN- Chemical group 0.000 claims 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 239000001257 hydrogen Substances 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 125000000304 alkynyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000006573 (C1-C10) heteroaryl group Chemical group 0.000 claims 2
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 2
- RGQPEMBJOFTNNB-UHFFFAOYSA-N 2-chloro-n-[(1-hydroxycycloheptyl)methyl]-5-[4-(2-hydroxy-3-methoxypropyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]benzamide Chemical compound O=C1N(CC(O)COC)C(C)=NN1C1=CC=C(Cl)C(C(=O)NCC2(O)CCCCCC2)=C1 RGQPEMBJOFTNNB-UHFFFAOYSA-N 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 102000000589 Interleukin-1 Human genes 0.000 claims 2
- 108010002352 Interleukin-1 Proteins 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 235000019000 fluorine Nutrition 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- RFPJMKABSJEKPH-UHFFFAOYSA-N 2-chloro-5-[4-(cyanomethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-n-[(1-hydroxycycloheptyl)methyl]benzamide Chemical compound O=C1N(CC#N)C(C)=NN1C1=CC=C(Cl)C(C(=O)NCC2(O)CCCCCC2)=C1 RFPJMKABSJEKPH-UHFFFAOYSA-N 0.000 claims 1
- LJVLXMYFZRVQHX-UHFFFAOYSA-N 2-chloro-5-[4-(cyanomethyl)-5-oxo-1,2,4-triazol-1-yl]-n-[(1-hydroxycycloheptyl)methyl]benzamide Chemical compound C=1C(N2C(N(CC#N)C=N2)=O)=CC=C(Cl)C=1C(=O)NCC1(O)CCCCCC1 LJVLXMYFZRVQHX-UHFFFAOYSA-N 0.000 claims 1
- UKDIGJHGQVHHHP-UHFFFAOYSA-N 2-chloro-n-[(1-hydroxy-3,3-dimethylcyclohexyl)methyl]-5-(5-methyl-3-oxo-1h-1,2,4-triazol-2-yl)benzamide Chemical compound O=C1NC(C)=NN1C1=CC=C(Cl)C(C(=O)NCC2(O)CC(C)(C)CCC2)=C1 UKDIGJHGQVHHHP-UHFFFAOYSA-N 0.000 claims 1
- RCTDSGVXRWTORZ-UHFFFAOYSA-N 2-chloro-n-[(1-hydroxycycloheptyl)methyl]-5-(3-oxo-1h-1,2,4-triazol-2-yl)benzamide Chemical compound C=1C(N2C(NC=N2)=O)=CC=C(Cl)C=1C(=O)NCC1(O)CCCCCC1 RCTDSGVXRWTORZ-UHFFFAOYSA-N 0.000 claims 1
- YOSWOAOSZWTECO-UHFFFAOYSA-N 2-chloro-n-[(1-hydroxycycloheptyl)methyl]-5-(5-methyl-3-oxo-1h-1,2,4-triazol-2-yl)benzamide Chemical compound O=C1NC(C)=NN1C1=CC=C(Cl)C(C(=O)NCC2(O)CCCCCC2)=C1 YOSWOAOSZWTECO-UHFFFAOYSA-N 0.000 claims 1
- FHLQCVGMVRPOSI-UHFFFAOYSA-N 2-chloro-n-[(1-hydroxycycloheptyl)methyl]-5-[4-(2-hydroxyethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]benzamide Chemical compound O=C1N(CCO)C(C)=NN1C1=CC=C(Cl)C(C(=O)NCC2(O)CCCCCC2)=C1 FHLQCVGMVRPOSI-UHFFFAOYSA-N 0.000 claims 1
- CSWDVEPPNDYGGX-UHFFFAOYSA-N 2-chloro-n-[(1-hydroxycycloheptyl)methyl]-5-[4-(2-methoxyethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]benzamide Chemical compound O=C1N(CCOC)C(C)=NN1C1=CC=C(Cl)C(C(=O)NCC2(O)CCCCCC2)=C1 CSWDVEPPNDYGGX-UHFFFAOYSA-N 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- JZGBEXCGSAJKCR-UHFFFAOYSA-N 5-[4-(2-aminoethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-2-chloro-n-[(1-hydroxycycloheptyl)methyl]benzamide Chemical compound O=C1N(CCN)C(C)=NN1C1=CC=C(Cl)C(C(=O)NCC2(O)CCCCCC2)=C1 JZGBEXCGSAJKCR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 0 *c1ccc(*)c(C(N*)=O)c1 Chemical compound *c1ccc(*)c(C(N*)=O)c1 0.000 description 8
- YEJJUJNTWYKFLS-UHFFFAOYSA-N CCC(N1CCCC1)=O Chemical compound CCC(N1CCCC1)=O YEJJUJNTWYKFLS-UHFFFAOYSA-N 0.000 description 1
- MTJVUMGKHCIMJL-UHFFFAOYSA-N CCC(N1CCCCC1)=O Chemical compound CCC(N1CCCCC1)=O MTJVUMGKHCIMJL-UHFFFAOYSA-N 0.000 description 1
- YEQAMPOYHLICPF-UHFFFAOYSA-N CCC(N1CCNCC1)=O Chemical compound CCC(N1CCNCC1)=O YEQAMPOYHLICPF-UHFFFAOYSA-N 0.000 description 1
- PXHFWPOPKVWXQT-UHFFFAOYSA-N CN(C=CN1)C1=O Chemical compound CN(C=CN1)C1=O PXHFWPOPKVWXQT-UHFFFAOYSA-N 0.000 description 1
- ILQNVRGOXXBGCI-UHFFFAOYSA-N CN1N=CNC1=O Chemical compound CN1N=CNC1=O ILQNVRGOXXBGCI-UHFFFAOYSA-N 0.000 description 1
- SAEJJZSYLNCLIG-UHFFFAOYSA-O COC(CN)C[OH2+] Chemical compound COC(CN)C[OH2+] SAEJJZSYLNCLIG-UHFFFAOYSA-O 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43722802P | 2002-12-31 | 2002-12-31 | |
| PCT/IB2003/006232 WO2004058731A1 (fr) | 2002-12-31 | 2003-12-30 | Inhibiteurs benzamidiques du recepteur p2x7 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006513205A JP2006513205A (ja) | 2006-04-20 |
| JP2006513205A5 true JP2006513205A5 (fr) | 2007-02-08 |
Family
ID=32682421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004563508A Withdrawn JP2006513205A (ja) | 2002-12-31 | 2003-12-30 | Ｐ２ｘ７受容体のベンズアミド阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1581507A1 (fr) |
| JP (1) | JP2006513205A (fr) |
| AU (1) | AU2003288640A1 (fr) |
| BR (1) | BR0317844A (fr) |
| CA (1) | CA2511189A1 (fr) |
| MX (1) | MXPA05007130A (fr) |
| WO (1) | WO2004058731A1 (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7071223B1 (en) | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| ES2396565T3 (es) | 2003-05-12 | 2013-02-22 | Pah Usa 15 Llc | Inhibidores benzamida del receptor P2X7 |
| EP1837330B1 (fr) * | 2003-05-12 | 2012-10-24 | Pfizer Products Inc. | Inhibiteurs benzamidiques du recepteur P2X7 |
| CN1980902A (zh) | 2004-06-29 | 2007-06-13 | 辉瑞产品有限公司 | 通过对羟基保护前体去保护而制备5－4－(2－羟基－丙基)－3，5－二氧代－4，5－二氢－3h－[1，2，4]三嗪－2－基－苯甲酰胺衍生物的方法 |
| AU2005278918B2 (en) * | 2004-08-31 | 2010-07-29 | Sylentis S.A.U. | Methods and compositions to inhibit P2X7 receptor expression |
| EP1951689A1 (fr) | 2005-11-07 | 2008-08-06 | Abbott Laboratories | Antagonistes des recepteurs p2x7 et methodes d'utilisation |
| PT2105164E (pt) | 2008-03-25 | 2011-03-24 | Affectis Pharmaceuticals Ag | Novos antagonistas de p2x7r e a sua utilização |
| AU2010237302A1 (en) | 2009-04-14 | 2011-12-01 | Affectis Pharmaceuticals Ag | Novel P2X7R antagonists and their use |
| EA201290876A1 (ru) | 2010-03-05 | 2013-03-29 | Президент Энд Феллоуз Оф Гарвард Колледж | Композиции индуцированных дендритных клеток и их использование |
| CN102858741A (zh) | 2010-05-14 | 2013-01-02 | 阿费克蒂斯制药股份公司 | 制备p2x7r拮抗剂的新方法 |
| SG189156A1 (en) * | 2010-10-01 | 2013-05-31 | Taisho Pharmaceutical Co Ltd | 1,2,4-triazolone derivative |
| WO2012110190A1 (fr) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Nouveaux antagonistes p2x7r et leur utilisation |
| WO2012114268A1 (fr) | 2011-02-22 | 2012-08-30 | Actelion Pharmaceuticals Ltd | Dérivés de benzamide en tant qu'antagonistes du récepteur p2x7 |
| WO2012163792A1 (fr) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Nouveaux antagonistes de p2x7r et leur utilisation |
| WO2012163456A1 (fr) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Nouveaux antagonistes de p2x7r et leur utilisation |
| ES2574840T3 (es) | 2011-07-22 | 2016-06-22 | Actelion Pharmaceuticals Ltd. | Derivados de amidas heterocíclicas como antagonistas de receptores p2x7 |
| NZ628910A (en) | 2012-01-20 | 2016-02-26 | Actelion Pharmaceuticals Ltd | Heterocyclic amide derivatives as p2x7 receptor antagonists |
| TWI568722B (zh) * | 2012-06-15 | 2017-02-01 | 葛蘭馬克製藥公司 | 作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物 |
| ES2618056T3 (es) | 2012-12-12 | 2017-06-20 | Actelion Pharmaceuticals Ltd. | Derivados de indol carboxamida como antagonistas del receptor P2X7 |
| AR094053A1 (es) | 2012-12-18 | 2015-07-08 | Actelion Pharmaceuticals Ltd | Derivados de indol carboxamida como antagonistas del receptor p2x₇ |
| WO2014115078A1 (fr) | 2013-01-22 | 2014-07-31 | Actelion Pharmaceuticals Ltd | Dérivés d'amides hétérocycliques utilisés comme antagonistes du récepteur p2x7 |
| ES2616114T3 (es) | 2013-01-22 | 2017-06-09 | Actelion Pharmaceuticals Ltd. | Derivados de amida heterocíclica como antagonistas del receptor P2X7 |
| US9988373B2 (en) | 2013-12-26 | 2018-06-05 | Shionogi & Co., Ltd. | Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same |
| EP3957627B1 (fr) | 2015-04-24 | 2024-06-19 | Shionogi & Co., Ltd | Dérivé hétérocyclique à 6 chainons et composition pharmaceutique le comprenant |
| WO2018074390A1 (fr) | 2016-10-17 | 2018-04-26 | 塩野義製薬株式会社 | Dérivé hétérocyclique azoté bicyclique et composition pharmaceutique le comprenant |
| WO2020036133A1 (fr) * | 2018-08-17 | 2020-02-20 | クミアイ化学工業株式会社 | Dérivé d'amide d'acide 3-(1h-1,2,4-triazole-1-yl) benzoïque et agent de lutte contre des organismes nuisibles |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4405614A1 (de) * | 1994-02-22 | 1995-08-24 | Bayer Ag | Substituierte Triazolinone |
| EA003056B1 (ru) * | 1996-12-23 | 2002-12-26 | Дюпон Фармасьютикалз Компани | АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ |
| PA8557501A1 (es) * | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
-
2003
- 2003-12-30 EP EP03780483A patent/EP1581507A1/fr not_active Withdrawn
- 2003-12-30 CA CA002511189A patent/CA2511189A1/fr not_active Abandoned
- 2003-12-30 AU AU2003288640A patent/AU2003288640A1/en not_active Abandoned
- 2003-12-30 BR BR0317844-7A patent/BR0317844A/pt not_active IP Right Cessation
- 2003-12-30 JP JP2004563508A patent/JP2006513205A/ja not_active Withdrawn
- 2003-12-30 WO PCT/IB2003/006232 patent/WO2004058731A1/fr active Application Filing
- 2003-12-30 MX MXPA05007130A patent/MXPA05007130A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006513205A5 (fr) | ||
| JP2006513206A5 (fr) | ||
| CA2512193A1 (fr) | Derives de 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide utilises comme inhibiteurs de p2x7 pour le traitement de maladies inflammatoires | |
| JP2006506443A5 (fr) | ||
| JP2006515339A5 (fr) | ||
| JP2008514732A5 (fr) | ||
| JP2008534453A5 (fr) | ||
| JP2007516205A5 (fr) | ||
| JP2004509061A5 (fr) | ||
| RU2007116119A (ru) | Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с | |
| JP2015526448A5 (fr) | ||
| JP2006509749A5 (fr) | ||
| JP2008535903A5 (fr) | ||
| JP2010501584A5 (fr) | ||
| JP2004516314A5 (fr) | ||
| JP2002539128A5 (fr) | ||
| JP2019500387A5 (fr) | ||
| JP2008528624A5 (fr) | ||
| JP2014532716A5 (fr) | ||
| JP2007520452A5 (fr) | ||
| RU2008139195A (ru) | Замещенные арилсульфанамиды как противовирусные средства | |
| JP2002525323A5 (fr) | ||
| JP2006511446A5 (fr) | ||
| JP2002515427A5 (fr) | ||
| JP2007500222A5 (fr) |